Chemours Commends the U.S. Senate for Ratification of the Kigali Amendment
2022-09-25
WILMINGTON, Del.--(BUSINESS WIRE)-- The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, commends the U.S. Senate for ratifying the Kigali Amendment to the Montreal Protocol. The U.S. joins approximately 140 other parties that have joined the international agreement to decrease the production and consumption of hydrofluorocarbons (HFCs) by more than 80% over the next 30 years.